Cargando…

Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019

The objective of this study is to update earlier work on intramammary (IM) antimicrobial (AM) usage in Ireland. There is a need to measure AM usage in food-producing animals given increasing societal concerns about AM resistance as well as recent regulatory changes that dictate changes in how AM are...

Descripción completa

Detalles Bibliográficos
Autores principales: McAloon, Catherine I., McCoy, Finola, More, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623689/
https://www.ncbi.nlm.nih.gov/pubmed/36338384
http://dx.doi.org/10.3168/jdsc.2021-0081
_version_ 1784822058918608896
author McAloon, Catherine I.
McCoy, Finola
More, Simon J.
author_facet McAloon, Catherine I.
McCoy, Finola
More, Simon J.
author_sort McAloon, Catherine I.
collection PubMed
description The objective of this study is to update earlier work on intramammary (IM) antimicrobial (AM) usage in Ireland. There is a need to measure AM usage in food-producing animals given increasing societal concerns about AM resistance as well as recent regulatory changes that dictate changes in how AM are used in food-producing animals and how AM sales and usage are recorded. National sales data were collected and used in this analysis. Sales of the number of IM AM tubes and amount of active ingredient sold were analyzed each year by product type [in-lactation (LC) therapy and dry cow (DC) therapy] and classification system (World Health Organization and more recent European Medicine Agency). Descriptive trends in estimated IM AM use are presented, including defined course dose (DCDvet; a technical unit for on-farm usage). There has been a decrease in estimated on-farm usage of IM AM during lactation, from 0.48 DCDvet/cow per year in 2015 to 0.43 DCDvet/cow per year in 2019. Almost all LC therapies sold include critically important AM (CIA), with 98% of the total DCDvet administered for LC therapy in 2019 containing at least 1 CIA. There has been a slow increase in tubes containing at least 1 highest priority CIA in LC therapies, from 0.01 DCDvet/cow per year in 2003, accounting for 2% of the total DCDvet administered for LC therapy, to 0.03 DCDvet/cow per year in 2019, accounting for 7% of the total DCDvet administered for LC use. The estimated usage of IM AM DC therapy has decreased from 1.09 DCDvet/cow per year in 2015 to 0.95 DCDvet/cow per year in 2019. In the last 5 yr, more than 40% of the total DC DCDvet administered contained at least 1 CIA, and there has been an increase in recent years in the percentage of the total DC DCDvet administered that contains at least 1 highest priority CIA, driven mainly by use of fourth-generation cephalosporin. This work provides further insights into IM AM usage in Ireland and highlights some important areas for attention, including availability of farm-level usage data, prescribing practices, and usage of important AM.
format Online
Article
Text
id pubmed-9623689
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96236892022-11-04 Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019 McAloon, Catherine I. McCoy, Finola More, Simon J. JDS Commun Health, Behavior, and Well-being The objective of this study is to update earlier work on intramammary (IM) antimicrobial (AM) usage in Ireland. There is a need to measure AM usage in food-producing animals given increasing societal concerns about AM resistance as well as recent regulatory changes that dictate changes in how AM are used in food-producing animals and how AM sales and usage are recorded. National sales data were collected and used in this analysis. Sales of the number of IM AM tubes and amount of active ingredient sold were analyzed each year by product type [in-lactation (LC) therapy and dry cow (DC) therapy] and classification system (World Health Organization and more recent European Medicine Agency). Descriptive trends in estimated IM AM use are presented, including defined course dose (DCDvet; a technical unit for on-farm usage). There has been a decrease in estimated on-farm usage of IM AM during lactation, from 0.48 DCDvet/cow per year in 2015 to 0.43 DCDvet/cow per year in 2019. Almost all LC therapies sold include critically important AM (CIA), with 98% of the total DCDvet administered for LC therapy in 2019 containing at least 1 CIA. There has been a slow increase in tubes containing at least 1 highest priority CIA in LC therapies, from 0.01 DCDvet/cow per year in 2003, accounting for 2% of the total DCDvet administered for LC therapy, to 0.03 DCDvet/cow per year in 2019, accounting for 7% of the total DCDvet administered for LC use. The estimated usage of IM AM DC therapy has decreased from 1.09 DCDvet/cow per year in 2015 to 0.95 DCDvet/cow per year in 2019. In the last 5 yr, more than 40% of the total DC DCDvet administered contained at least 1 CIA, and there has been an increase in recent years in the percentage of the total DC DCDvet administered that contains at least 1 highest priority CIA, driven mainly by use of fourth-generation cephalosporin. This work provides further insights into IM AM usage in Ireland and highlights some important areas for attention, including availability of farm-level usage data, prescribing practices, and usage of important AM. Elsevier 2021-07-01 /pmc/articles/PMC9623689/ /pubmed/36338384 http://dx.doi.org/10.3168/jdsc.2021-0081 Text en © 2021. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Health, Behavior, and Well-being
McAloon, Catherine I.
McCoy, Finola
More, Simon J.
Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title_full Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title_fullStr Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title_full_unstemmed Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title_short Trends in estimated intramammary antimicrobial usage in the Irish dairy industry from 2003 to 2019
title_sort trends in estimated intramammary antimicrobial usage in the irish dairy industry from 2003 to 2019
topic Health, Behavior, and Well-being
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623689/
https://www.ncbi.nlm.nih.gov/pubmed/36338384
http://dx.doi.org/10.3168/jdsc.2021-0081
work_keys_str_mv AT mcalooncatherinei trendsinestimatedintramammaryantimicrobialusageintheirishdairyindustryfrom2003to2019
AT mccoyfinola trendsinestimatedintramammaryantimicrobialusageintheirishdairyindustryfrom2003to2019
AT moresimonj trendsinestimatedintramammaryantimicrobialusageintheirishdairyindustryfrom2003to2019